Picture of Gian Life Care logo

542918 Gian Life Care Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapContrarian

Momentum

Relative Strength (%)
1m-18.94%
3m-11.24%
6m-18.01%
1yr-33.49%
Volume Change (%)
10d/3m-61.78%
Price vs... (%)
52w High-30.14%
50d MA-11.69%
200d MA-7.14%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.33
Price to Tang. Book1.33
Price to Free Cashflow19.31
Price to Sales1.91
EV to EBITDA4.61

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.79%
Return on Equity15.23%
Operating Margin27.32%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m5.5876.45104.55159.3119.25n/an/a114.98%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+1365.38+37.1+116.86-75.65n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Gian Life Care EPS forecast chart

Profile Summary

Gian Life Care Limited is an India-based company. The Company is engaged in the business of providing diagnostic and related healthcare tests and services in various cities connecting Kanpur and nearby areas. The Company offers a range of approximately 1,344 tests, which includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology and hematology, among others. The Company provides a range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. The Company is focused on opening several diagnostics labs in various parts of the State. Its subsidiaries include Gian Path Lab (India) Pvt Ltd and Gian Satguru Pathology LLP. Its customers include individual patients, hospitals, other healthcare providers and corporate customers.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
November 6th, 2018
Public Since
January 13th, 2020
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
10,341,524

542918 Share Price Performance

Upcoming Events for 542918

Q4 2024 Gian Life Care Ltd Earnings Release

Q1 2025 Gian Life Care Ltd Earnings Release

Gian Life Care Ltd Annual Shareholders Meeting

Similar to 542918

Picture of Aashka Hospitals logo

Aashka Hospitals

in flag iconBombay Stock Exchange

Picture of ADS Diagnostic logo

ADS Diagnostic

in flag iconBombay Stock Exchange

Picture of Asarfi Hospital logo

Asarfi Hospital

in flag iconBombay Stock Exchange

Picture of Aspira Pathlab & Diagnostics logo

Aspira Pathlab & Diagnostics

in flag iconBombay Stock Exchange

FAQ